Advertisement
Berita Valas
Swiss Market Ends Weak For 7th Straight Day
Swiss stocks tumbled on Friday, tracking weakness in global markets amid concerns over higher borrowing costs, an escalation in tensions in the Middle East, and rising bond yields.
RTTNews |
703 days ago
European Stocks Close Sharply Lower
European stocks fell sharply on Friday with investors rushing for safe-haven assets as rising Treasury yields, higher interest rates and escalating tensions in the Middle East hurt risk sentiment.
RTTNews
|
703 days ago
MetroCity Bankshares Q3 Profit Declines
MetroCity Bankshares, Inc. (MCBS), holding company for Metro City Bank, reported Friday that net income for the third quarter declined to $11.43 million or $0.45 per share from $16.89 million or $0.66 per share in the prior-year quarter.
RTTNews
|
704 days ago
GMS Board Approves $250 Mln Share Repurchase Program
GMS Inc. (GMS), a specialty distributor of interior building products, announced Friday that its Board of Directors have approved a share repurchase program under which it is authorized to repurchase up to $250 million of its outstanding common stock.
RTTNews
|
704 days ago
Virginia National Bankshares Q3 Profit Declines
Virginia National Bankshares Corp. (VABK) reported Friday that net income for the third quarter declined to $4.7 million or $0.86 per share from $5.8 million or $1.08 per share in the prior-year quarter.
RTTNews
|
704 days ago
CVS To Remove Some Cold, Cough Medicines With Phenylephrine
CVS Health is removing certain over-the-counter or OTC cold and cough products with phenylephrine as the only active ingredient from its Pharmacy stores, reports said. The decision follows the U.S. Food and Drug Administration Advisory Committee's position on oral phenylephrine or PE.
RTTNews
|
704 days ago
Lipella Pharma Soars 48% After FDA Oks IND For LP-310 For Oral Lichen Planus
Biotechnology company Lipella Pharmaceuticals Inc. (LIPO) announced Friday that the U.S. Food and Drug Administration (FDA) has approved an Investigational New Drug (IND) application for a multi-center, phase-2a, dose-escalation clinical trial.
RTTNews
|
704 days ago
more news
Bay Street Likely To Open Lower On Weak Global Cues
Global cues point to a weak start on Bay Street Friday morning, but rising crude oil and bullion prices may trigger some buying in energy and materials sectors and help limit market's downside.
RTTNews
|
704 days ago
American Express Backs FY23 Outlook - Update
While reporting financial results for the third quarter on Friday, American Express Co. (AXP) backed its earnings and revenue growth guidance for the full-year 2023.
RTTNews
|
704 days ago
Sensex, Nifty Extend Losses For Third Day On Weak Global Cues
Indian shares fell for a third day running on Friday as global markets slumped on concerns over rising bond yields and escalating tensions in the Middle East.
RTTNews
|
704 days ago
Pound Falls Amid War Worries, Downbeat Retail Sales Data
The British pound weakened against other major currencies in the European session on Friday, as European shares traded lower amid worries over rising bond yields and the escalating Israel-Hamas conflict.
RTTNews
|
704 days ago
European Shares Extend Losses On Fears About Wider Middle East Conflict
European stocks traded lower on Friday to extend recent losses as expectations of higher-for-longer interest rates and an escalating Middle East conflict dented investors' appetite for risk.
RTTNews
|
704 days ago
FTSE 100 Declines As Retail Sales Disappoint
U.K. stocks traded lower on Friday amid worries over rising bond yields and the escalating Israel-Hamas conflict.
RTTNews
|
704 days ago
Stay up to date!
Add Berita to your browser
Add To Chrome
